Portfolio Insights BlackRock

The 2024 market is the 2nd most active year ever for biotech follow-on issuance by proceeds raised. Data on China’s innovative drug outbound transaction volume and value is sourced from Pharmcube (医药魔方) NextPharma® Global Innovative Drug Database. The chart below illustrates recent trends in China’s outbound drug licensing, highlighting both deal counts and upfront payments.

• People gaining greater ownership of their health through access to data, diagnostics, and AI supported insights is transformational.
• Meta is reportedly planning to open source its upcoming AI models as the company continues to struggle with user adoption of its current AI offerings.
• Rather, an assessment should be made as to whether the information is appropriate in individual circumstances and consideration should be given to talking to a financial professional before making an investment decision.
• Small and mid-sized employers (those with fewer than 1,000 workers) are particularly affected by these rising costs.3 Regardless of the cost increases, employers remain focused on providing competitive benefits to attract and retain top talent.

Subscribe to M&A Spotlight

We’ve seen two mega forces – AI and geopolitical fragmentation – collide so far this year. The Middle East conflict delivered a supply shock, disrupting the flow of energy and other key materials like fertilizer and gas. But at the same time, mega cap tech “hyperscalers” are slated to spend even more than previously thought.

Provider Services and Technology Integration

Activity in H1’25 was concentrated in third-party administrators (TPAs), compliance platforms, and value-based care enablers.3 The absence of mega-deals signals a shift toward operational optimization and risk management. Keynote addresses from senior government officials made the case for greater data integration in the public sector, as well as the launch of a “health tech ecosystem” that can provide Medicare enrollees easier access to innovative health technologies. Technology-enabled care continues to be a priority, with virtual care growing in fields like chronic care management. Government organizations aim to move faster in 2026, focusing on digital-first solutions across drug development, data management and diagnostics.

Key trends shaping Healthcare M&A:

It's operational performance improvements that you can see with technology and artificial intelligence. KPMG has market-leading alliances with many of the world's leading software and services vendors. This is where AI can have the greatest impact, streamlining how care is delivered, documented, approved, and paid for. We’re moving from a system centered on facilities to one where care is delivered directly to individuals in their homes, in a more personalized way. Technology is advancing at a much faster pace, and policy uncertainty is higher, which adds complexity. At the same time, there is significant capital available to deploy and a more favorable interest rate environment, which supports optimism for 2026.

In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. J.P. Morgan’s 44th annual Healthcare Conference, the industry’s largest and most informative healthcare event, recently wrapped up in San Francisco. Connecting https://open-innovation-projects.org/blog/open-source-software-revolutionizing-healthcare-a-comprehensive-guide-for-professionals global investors, industry leaders, high-growth companies, innovative technology creators and senior government officials, the conference provides crucial insight into what lies ahead for the industry. Though nascent now, looking further ahead AI may have application in drug discovery and development.

• Explore key findings from BlackRock’s 2025 investor survey on ETF investing — emerging demographics, investor motivations, and barriers to entry.
• The deal comes as major pharmaceutical companies like Sanofi, Novo Nordisk, and AbbVie increasingly integrate Claude into their operations, and follows Eli Lilly's recent $2.75 billion investment in Insilico Medicine's AI-driven drug design platform.
• This represents a shift from pure deep learning toward more structured AI architectures that can better handle reasoning and rule-based tasks.
• Fewer countries have adopted or enforced rights-based mental health legislation, and only 45% of countries evaluated laws in full compliance with international human rights standards.
• Explore the journey of bitcoin's volatility, from turbulent beginnings to a promising decline.
• The $18.3 billion take‑private of Hologic by Blackstone and TPG completed on 7 April marks a significant milestone, signalling that investors see long‑term strategic value in women’s health portfolios.